| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK-4112 |
|---|
| Description | GSK-4112 is a selective agonist for REV-ERBα (EC50 = 0.4 μM). At 10 μM, GSK-4112 can reset the circadian rhythm in a phasic manner by inhibiting expression of the circadian target gene bmal1 and reduce glucose output by 30% in mouse primary hepatocytes by repressing the expression of several gluconeogenic genes. GSK-4112 is useful as a chemical tool to probe the function of REV-ERbα in transcriptional repression, regulation of circadian biology, and metabolic pathways. MW: 396.89. Purity ≥98% |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1,1-Dimethylethyl-N-[(4-chlorophenyl)methyl]-N-[(5-nitro-2-thienyl)methyl])glycinate; SR 6452 |
|---|
| Gene, Accession, CAS # | CAS: 1216744-19-2 |
|---|
| Catalog # | 9663-25 |
|---|
| Price | |
|---|
| Order / More Info | GSK-4112 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|